MenACWY vaccination among adolescents by state U.S. 2017| ��ƽ��

Percentage of adolescents in the U.S. who had received a MenACWY vaccination as of 2017, by state*

Characteristic	Percentage of adolescents
U.S. overall	85.1%
Connecticut	94.9%
Maine	83.9%
Massachusetts	94%
New Hampshire	87.9%
Rhode Island	94.1%
Vermont	84.2%
New Jersey	93.3%
New York	89.3%
Delaware	90.5%
District of Columbia	91.3%
Maryland	91.8%
Pennsylvania	93.4%
Virginia	80%
West Virginia	87.9%
Alabama	78.3%
Florida	80.2%
Georgia	95.3%
Kentucky	83.3%
Mississippi	63%
North Carolina	84.8%
South Carolina	78.6%
Tennessee	75%
Illinois	89.2%
Indiana	93.1%
Michigan	93.5%
Minnesota	87.5%
Ohio	87.3%
Wisconsin	83.8%
Arkansas	91.7%
Louisiana	89%
New Mexico	78%
Oklahoma	71.1%
Texas	85.1%
Iowa	83.6%
Kansas	72.1%
Missouri	74.3%
Nebraska	84.8%
Colorado	82.4%
Montana	71.2%
North Dakota	91.9%
South Dakota	74.5%
Utah	85.1%
Wyoming	60.7%
Arizona	83.8%
California	82.2%
Hawaii	85.9%
Nevada	77.3%
Alaska	68.4%
Idaho	90.5%
Oregon	77%
Washington	82.6%

Download

Source

Show detailed source information?

Already a member?

Sources

Release date

August 2018

More information

Region

United States

Survey time period

2017

Number of respondents

20,949 adolescents

Age group

13-17 years

Special properties

parents and guardians of adolescents

Method of interview

Telephone interview

Supplementary notes

* MenACWY = quadrivalent meningococcal conjugate vaccine. One or more doses of MenACWY or meningococcal-unknown type vaccine.

Citation formats

This statistic shows the percentage of adolescents in the U.S. that had a MenACWY (meningitis) vaccine as of 2017, by state. As of that time, around 95 percent of adolescents in Connecticut had received a MenACWY vaccination.